Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-03

Clinical Trial Update: BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study [Phase 2]

View source ↗

Summary

A Phase 2 proof-of-concept trial of bezafibrate for bipolar depression is currently recruiting, sponsored by Massachusetts General Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bezafibrate (bezafibrate)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Bipolar Disorder, Depressive Episode | Phase 2 | Status: RECRUITING